ArticleACS central science2020

Glycoengineering of Natural Killer Cells with CD22 Ligands for Enhanced Anticancer Immunotherapy.

Xianwu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.